Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population (STEPS)

This study has been completed.
Sponsor:
Collaborator:
USDA Beltsville Human Nutrition Research Center
Information provided by:
Pennington Biomedical Research Center
ClinicalTrials.gov Identifier:
NCT01264757
First received: December 3, 2010
Last updated: December 20, 2010
Last verified: December 2010

December 3, 2010
December 20, 2010
February 2010
June 2010   (final data collection date for primary outcome measure)
Minutes spent in moderate-to-vigorous physical activity (MVPA) [ Time Frame: The primary outcome is measured at baseline and after a 7-day intervention period (1 week) ] [ Designated as safety issue: No ]
A GT3X accelerometer is used to monitor each participants physical activity levels for seven consecutive days at baseline and again following a 7-day intervention period. The amount of time per day spent above a threshold of 2200 accelerometer counts/min is averaged over at least three days as the measure of MVPA.
Same as current
Complete list of historical versions of study NCT01264757 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population
Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population

This feasibility study specifically addresses the issue of adapting US dietary guidelines physical activity recommendations to the population of the Lower Mississippi Delta. The hypothesis is that including a pedometer as a self-monitoring tool as part of adapted physical activity guidelines will result in greater immediate increases in physical activity (as monitored by an accelerometer) than an education program alone.

The purpose of this study was to determine if a short-term pedometer-based intervention results in immediate increases in time spent in moderate-to-vigorous physical activity (MVPA) compared to a minimal educational intervention.A sample of 43 overweight adults 35 to 64 years of age participated in a one week pedometer-based feasibility trial monitored by accelerometry. Participants were randomized into a one-week education-only group or a group that also wore a pedometer. Accelerometer-measured MVPA was measured over 7 days at baseline and post-intervention.

Interventional
Phase 0
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Physical Inactivity
  • Behavioral: Physical Activity Educational Materials
    A brochure was provided to participants about the health benefits of physical activity and physical activity recommendations
  • Behavioral: Pedometer
    A pedometer was provided to participants in addition to educational materials about the health benefits of physical activity.
  • Active Comparator: Education
    Educational brochure about physical activity provided.
    Intervention: Behavioral: Physical Activity Educational Materials
  • Experimental: Pedometer
    A pedometer was provided in addition to educational materials.
    Intervention: Behavioral: Pedometer
Katzmarzyk PT, Champagne CM, Tudor-Locke C, Broyles ST, Harsha D, Kennedy BM, Johnson WD. A short-term physical activity randomized trial in the Lower Mississippi Delta. PLoS One. 2011;6(10):e26667. doi: 10.1371/journal.pone.0026667. Epub 2011 Oct 25.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
43
June 2010
June 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 35 to 64 years of age
  • body mass index (BMI) between 25 and 34.9 kg/m2
  • being able to walk without limitation

Exclusion Criteria:

  • cardiovascular, respiratory, gastrointestinal, neuromuscular, neurological, or psychiatric problems; musculoskeletal problems interfering with exercise
  • immunodeficiency problems
  • malignancies in the last 5 years
  • any other medical condition or life threatening disease that could be aggravated by exercise
Both
35 Years to 64 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01264757
PBRC29034
No
Peter T. Katzmarzyk, Pennington Biomedical Research Center
Pennington Biomedical Research Center
USDA Beltsville Human Nutrition Research Center
Principal Investigator: Peter T Katzmarzyk, PhD Pennington Biomedical Research Center
Pennington Biomedical Research Center
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP